skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 5,064  for All Library Resources

previous page 1 Results 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy
Material Type:
Article
Add to My Research

Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 2013-10, Vol.62 (14), p.1252-1259 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2013 American College of Cardiology Foundation ;2014 INIST-CNRS ;Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 1, 2013 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.03.055 ;PMID: 23623916 ;CODEN: JACCDI

Full text available

22
Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction
Material Type:
Article
Add to My Research

Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction

Heart (British Cardiac Society), 2023-05, Vol.109 (10), p.771-778 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-321853 ;PMID: 36581445

Full text available

23
Doxorubicin Cardiomyopathy
Material Type:
Article
Add to My Research

Doxorubicin Cardiomyopathy

Cardiology, 2010-01, Vol.115 (2), p.155-162 [Peer Reviewed Journal]

2009 S. Karger AG, Basel ;Copyright © 2009 by S. Karger AG, Basel 2009 ;ISSN: 0008-6312 ;EISSN: 1421-9751 ;DOI: 10.1159/000265166 ;PMID: 20016174

Full text available

24
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
Material Type:
Article
Add to My Research

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 2010-09, Vol.56 (11), p.875-887 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2010 American College of Cardiology Foundation ;2015 INIST-CNRS ;Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Sep 7, 2010 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2010.05.007 ;PMID: 20667520 ;CODEN: JACCDI

Full text available

25
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy
Material Type:
Article
Add to My Research

Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy

Journal of the American College of Cardiology, 2015-11, Vol.66 (18), p.1990-1999 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2015 American College of Cardiology Foundation ;Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Nov 3, 2015 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.08.879 ;PMID: 26516002

Full text available

26
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Material Type:
Article
Add to My Research

SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor

Cardiovascular drugs and therapy, 2017-04, Vol.31 (2), p.119-132 [Peer Reviewed Journal]

Springer Science+Business Media New York 2017 ;Cardiovascular Drugs and Therapy is a copyright of Springer, 2017. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-017-6725-2 ;PMID: 28447181

Full text available

27
Alcoholic Cardiomyopathy: Pathophysiologic Insights
Material Type:
Article
Add to My Research

Alcoholic Cardiomyopathy: Pathophysiologic Insights

Cardiovascular toxicology, 2014-12, Vol.14 (4), p.291-308 [Peer Reviewed Journal]

Springer Science+Business Media New York 2014 ;COPYRIGHT 2014 Springer ;ISSN: 1530-7905 ;EISSN: 1559-0259 ;DOI: 10.1007/s12012-014-9252-4 ;PMID: 24671642

Full text available

28
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
Material Type:
Article
Add to My Research

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

European heart journal, 2024-04, Vol.45 (16), p.1443-1454 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehae109 ;PMID: 38427064

Digital Resources/Online E-Resources

29
Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation
Material Type:
Article
Add to My Research

Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation

Heart (British Cardiac Society), 2016-03, Vol.102 (5), p.397-406 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2015-308037 ;PMID: 26740480

Full text available

30
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments
Material Type:
Article
Add to My Research

Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments

Heart failure reviews, 2022-07, Vol.27 (4), p.1173-1191 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 1382-4147 ;EISSN: 1573-7322 ;DOI: 10.1007/s10741-021-10139-0 ;PMID: 34263412

Full text available

31
B-Type Natriuretic Peptide and Survival in Hypertrophic Cardiomyopathy
Material Type:
Article
Add to My Research

B-Type Natriuretic Peptide and Survival in Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2456-2460 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2013 American College of Cardiology Foundation ;2014 INIST-CNRS ;Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 18, 2013 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.04.004 ;PMID: 23602778 ;CODEN: JACCDI

Full text available

32
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis

Heart (British Cardiac Society), 2019-04, Vol.105 (8), p.623-631 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2018-313700 ;PMID: 30366935

Full text available

33
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function
Material Type:
Article
Add to My Research

Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function

Journal of the American College of Cardiology, 2018-08, Vol.72 (8), p.857-870 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 21, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.05.060 ;PMID: 30115224

Full text available

34
Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2022-11, Vol.108 (22), p.1807-1814 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2021-320729 ;PMID: 35351822

Full text available

35
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series
Material Type:
Article
Add to My Research

Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series

Journal of the American College of Cardiology, 2018-03, Vol.71 (10), p.1149-1166 [Peer Reviewed Journal]

Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 13, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.01.017 ;PMID: 29519356

Full text available

36
Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping
Material Type:
Article
Add to My Research

Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping

The International Journal of Cardiovascular Imaging, 2018-11, Vol.34 (11), p.1769-1777 [Peer Reviewed Journal]

Springer Science+Business Media B.V., part of Springer Nature 2018 ;The International Journal of Cardiovascular Imaging is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1569-5794 ;EISSN: 1573-0743 ;EISSN: 1875-8312 ;DOI: 10.1007/s10554-018-1385-2 ;PMID: 29846837

Full text available

37
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Material Type:
Article
Add to My Research

Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy

Journal of the American College of Cardiology, 2006-11, Vol.48 (10), p.1977-1985 [Peer Reviewed Journal]

2006 American College of Cardiology Foundation ;Copyright Elsevier Limited Nov 21, 2006 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2006.07.049 ;PMID: 17112987

Full text available

38
Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?
Material Type:
Article
Add to My Research

Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?

Journal of the American College of Cardiology, 2016-08, Vol.68 (9), p.949-966 [Peer Reviewed Journal]

Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 30, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.05.096 ;PMID: 27561770

Full text available

39
How do mutations in contractile proteins cause the primary familial cardiomyopathies?
Material Type:
Article
Add to My Research

How do mutations in contractile proteins cause the primary familial cardiomyopathies?

Journal of cardiovascular translational research, 2011-06, Vol.4 (3), p.245 [Peer Reviewed Journal]

EISSN: 1937-5395 ;DOI: 10.1007/s12265-011-9266-2 ;PMID: 21424860

Digital Resources/Online E-Resources

40
Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2023-04, Vol.109 (8), p.589-594 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2020-316693 ;PMID: 36270782

Full text available

Results 21 - 40 of 5,064  for All Library Resources

previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1997  (8)
  2. 1997 To 2002  (128)
  3. 2003 To 2008  (698)
  4. 2009 To 2015  (1,743)
  5. After 2015  (2,488)
  6. More options open sub menu

Resource Type 

  1. Articles  (5,063)
  2. Books  (1)
  3. More options open sub menu

Language 

  1. English  (5,058)
  2. Japanese  (664)
  3. Dutch  (12)
  4. Portuguese  (10)
  5. German  (3)
  6. Norwegian  (2)
  7. French  (1)
  8. Turkish  (1)
  9. Spanish  (1)
  10. More options open sub menu

Searching Remote Databases, Please Wait